Voters blame insurers for medical debt: poll
More than 60% of respondents said insurance companies are most at fault for medical debt, compared with just 9% who blamed hospitals, according to a survey by nonprofit Undue Medical Debt.
More than 60% of respondents said insurance companies are most at fault for medical debt, compared with just 9% who blamed hospitals, according to a survey by nonprofit Undue Medical Debt.
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B Read More »
Genentech is letting go of 118 employees in San Francisco. The news comes about two months after the biotech ended a partnership with Adaptive Biotechnologies.
Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year Read More »
The operator increased its outlook after posting earnings growth in the third quarter, aided by strong demand for services in its acute business and a newly approved Medicaid state supplemental payment program.
Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a genetic thyroid disorder.
BridgeBio Shares Pop Again As Phase III Thyroid Drug Exceeds Investor Expectations Read More »
Shingrix sales in the U.S. took a 15% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales, after Sanofi reported a similar decline last week.
GSK Points to ‘Macro Factors’ to Explain U.S. Shingrix Demand Crash Read More »
El yacimiento arqueológico de Casas del Turuñuelo (Guareña, Badajoz, España) destaca por el relevante papel que tuvo este asentamiento en el comercio mediterráneo durante la época tartésica, en el siglo V antes de Cristo. En dicho yacimiento, …
Descubren el altar de mármol griego más antiguo del Mediterráneo occidental Read More »
The reprioritization initiative extends Aldeyra’s cash runway into the second half of 2027.
Aldeyra Cans RASP Asset, Brings Forward Two Others in Pipeline Shakeup Read More »
Despite the rejection, analysts saw Regeneron’s use of an alternate filler for Eylea HD as a positive development, with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise.
FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues Read More »
Una investigación reciente, usando mediciones del todo fiables, ha confirmado que se transfiere más calor entre objetos separados por tan solo unos pocos nanómetros de lo que se podría esperar de acuerdo con conceptos de la física hasta ahora tenidos por ciertos. E …
Un fenómeno desconocido de la física incrementa la transferencia de calor Read More »